Imupret oral drops 100 ml.

Description

Imupret drops Storage
active substances: 100 g of drops contain 29 g of aqueous-alcoholic extract (extractant ethanol 59% (v / v)) from medicinal plants:

marshmallow root (Radix Althaeae) 0.4 g;
chamomile flowers (Flores Chamomillae) 0.3 g;
horsetail herbs (Herba Equiseti) 0.5 g;
walnut leaves (Folia Juglandis) 0.4 g;
yarrow herb (Herba Millefolii) 0.4 g;
oak bark (Cortex Quercus) 0.2 g;
dandelion herb (Herba Taraxaci) 0.4 g;
excipients: ethanol 19% (v / v), purified water.

Imupret drops Dosage form
Oral drops.

Basic physical and chemical properties:

clear or slightly turbid yellow-brown liquid with the smell of chamomile. Turbidity and precipitation may occur during storage.

Imupret drops Pharmacotherapeutic group
Combination drugs used for coughs and colds. PBX code R05X.

Pharmacological properties
The components that make up the herbal medicine have a complex activity.

Thanks to the polysaccharides of chamomile and marshmallow, Imupret® stimulates a nonspecific reaction of the immune system by increasing the phagocytosis of macrophages and granulocytes. These active ingredients also increase the intracellular destruction of bacteria during phagocytosis due to increased secretion of active oxygen metabolites that have bactericidal properties. Polysaccharides, essential oils and flavonoids (chamomile, marshmallow and yarrow) reduce mucosal edema in respiratory infections. In vitro studies have shown that oak bark, which contains a lot of tannins, also has an antiviral effect on influenza virus.

Horsetail, which is part of the drug, enhances these effects due to its well-known healing and prophylactic properties.

Indication
For the treatment of diseases of the upper respiratory tract (tonsillitis, pharyngitis, laryngitis). Prevention of complications and recurrences of respiratory viral infections due to reduced body defenses

Contraindication
Hypersensitivity to any of the active substances or excipients of the drug and to plants of the family Compositae.

Special security measures
This medicine contains 19% ethanol.

Due to the ethanol content, Imupret® drops should not be prescribed after successful anti-alcohol treatment. Patients with liver disease, epilepsy, traumatic brain injury can take this drug only after consulting a doctor.

During storage, the drug may become cloudy or precipitate, but this does not affect the effect of the drug.

If the symptoms do not disappear after 1 week of treatment or there is shortness of breath, fever, purulent or bloody sputum, you should see a doctor.

Note for diabetics. A single dose of the drug contains a small number of bread units (CU).

Features of application
Use during pregnancy or breastfeeding.

Not recommended for use during pregnancy.

Ability to influence the speed of reaction when driving a car or working with other mechanisms.

There is no information on the direct effect of the drug on the ability to drive or use machines, but it should be borne in mind that the drug contains ethanol.